Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SMcTaggart
    Member
    • Jul 2010
    • 10

    #1

    Strange DE results

    Hello;

    I am using DESeq to determine which genes are differentially expressed between my treated sample and control. I am looking at three different genotypes (G1,G2,G3), each exposed to two different treatments (T1,T2), plus a control (C). For each treatment/genotype (e.g. G1T1) combination I have three replicates (G1T1R1, G1T1R2...). I am testing for differential expression between treated and control for each genotype/treatment combination.

    I am finding the results of the DE tests confusing. All of the DE genes in G1T1 are downregulated compared to controls, whereas most of the DE genes (~98%), in G2T1 are upregulated compared to controls. G3T1 in contrast, shows approximate equal numbers of up and downregulated genes. It seems possible to me that the first two patterns are a statistical artifact, and was wondering if anyone had some suggestions as to what could cause this? The volcano plots look symmetrical and the DE genes do not all lie close to the cut off curve.

    Many thanks for any ideas,

    Seanna

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...